This is a Phase 1/2, open-label, multicenter study evaluating the safety, tolerability, pharmacokinetics, pharmacodynamics and anti-tumor activity of TER-2013 …

Breast CancerEndometrial CancerOvarian Cancer+5 more

~Estimated

~$10 – $8,750

Terremoto Biosciences Inc.NCT07109726

Phase 1

A Modular Phase I/IIa, Open-label Study to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of Ascending Doses of AZD5335 Monotherapy and in Combination With Anti-cancer Agents in Participants With Solid Tumors

This research is designed to determine if experimental treatment with Antibody-drug conjugate, AZD5335, alone, or in combination with anti-cancer agents is saf…

Ovarian CancerLung AdenocarcinomaEndometrial Cancer+1 more

~Estimated

~$10 – $7,500

AstraZenecaNCT05797168